NCT05252390 2025-11-06
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Nuvation Bio Inc.
Phase 1 Terminated
Nuvation Bio Inc.
Cancer Research UK
Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes